Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Interest Expenses (2017 - 2025)

Updated

Adaptimmune Therapeutics' Interest Expenses was $962,000 in Q2 2025, up 82.9% from $526,000 a year earlier but down 48.9% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Interest Expenses (2017 - 2025) Analysis & Trends

On a trailing twelve-month basis, Adaptimmune Therapeutics' Interest Expenses was $5.67 million through Jun 30, 2025; for FY2024, it came in at $3.35 million.

  • Quarterly Interest Expenses has moved between $526,000 (Q2 2024) and $1.88 million (Q1 2025) over five years.
  • Per Business Quant data, ADAPY's Interest Expenses in the three quarters before Q2 2025 was $1.88 million (Q1 2025), $1.71 million (Q4 2024) and $1.11 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 962,000.00
Mar 31, 2025 1.88 Mn
Dec 31, 2024 1.71 Mn
Sep 30, 2024 1.11 Mn
Jun 30, 2024 526,000.00
Sep 30, 2017 8,000.00
Jun 30, 2017 6,000.00
API Access

Adaptimmune Therapeutics PLC Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ADAPY&period=max&api_key=YOUR_API_KEY